M
Maria Saumoy
Researcher at Bellvitge University Hospital
Publications - 61
Citations - 1310
Maria Saumoy is an academic researcher from Bellvitge University Hospital. The author has contributed to research in topics: Ritonavir & Medicine. The author has an hindex of 18, co-authored 54 publications receiving 1086 citations. Previous affiliations of Maria Saumoy include University of Barcelona & Carlos III Health Institute.
Papers
More filters
Journal ArticleDOI
Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study.
Esteban Martínez,Maria Larrousse,Josep M. Llibre,Félix Gutiérrez,Maria Saumoy,Antonio Antela,Hernando Knobel,Javier Murillas,Juan Berenguer,Judit Pich,Ignacio Pérez,José M. Gatell +11 more
TL;DR: In patients with sustained virological suppression on ritonavir-boosted protease inhibitor-based therapy, switching to raltegravir demonstrated noninferior efficacy and resulted in a better lipid profile at 48 weeks than continuing riton Cavir- boosted protease inhibitors.
Journal ArticleDOI
Cohorte RIS de pacientes con infección por VIH sin tratamiento antirretroviral previo (CoRIS): metodología y primeros resultados
Ana María Caro-Murillo,Jesús Castilla,S Perez-Hoyos,José Ma Miró,Daniel Podzamczer,Rafael Rubio,Melchor Riera,Pompeyo Viciana,José López Aldeguer,José Antonio Iribarren,Ignacio de los Santos-Gil,J.L. Gómez-Sirvent,Juan Berenguer,Félix Gutiérrez,Maria Saumoy,Ferran Segura,Vicente Soriano,Alejandro Peña,Federico Pulido,José Antonio Oteo,Manuel Leal,Jordi Casabona,Julia del Amo,Santiago Moreno +23 more
TL;DR: La metodologia CoRIS proporciona informacion relevante del perfil epidemiologico reciente de the infeccion by virus de the inmunodeficiencia humana (VIH) en nuestro medio, en el que predomina the transmision sexual.
Journal ArticleDOI
Delayed Diagnosis of HIV Infection in a Multicenter Cohort: Prevalence, Risk Factors, Response to HAART and Impact on Mortality
Paz Sobrino-Vegas,Lucía García San Miguel,Ana M. Caro Murillo,José M. Miró,Pompeyo Viciana,Cristina Tural,Maria Saumoy,Ignacio Santos,Julio Sola,Julia del Amo,Santiago Moreno,CoRIS +11 more
TL;DR: Although the authors did not find differences in virological and immunological responses to HAART, they did observe higher mortality in people with DHD, especially in older men, heterosexuals and IDUs.
Journal ArticleDOI
The Lipid-Lowering Effect of Tenofovir/Emtricitabine: A Randomized, Crossover, Double-Blind, Placebo-Controlled Trial
José R. Santos,Maria Saumoy,Adrian Curran,Isabel Bravo,Josep M. Llibre,Jordi Navarro,Carla Estany,Daniel Podzamczer,Esteban Ribera,Eugenia Negredo,Bonaventura Clotet,Roger Paredes +11 more
TL;DR: Coformulated TDF/FTC has an intrinsic lipid-lowering effect, likely attributable to TDF, and was associated with lower TC and LDL-c levels than placebo after 12 weeks.
Journal ArticleDOI
Body composition changes after switching from protease inhibitors to raltegravir: SPIRAL-LIP substudy.
Adrian Curran,Esteban Martínez,Maria Saumoy,Luis Del Rio,Manuel Crespo,Maria Larrousse,Daniel Podzamczer,Joaquin Burgos,Montse Loncá,Pere Domingo,José M. Gatell,Esteban Ribera +11 more
TL;DR: Although there were no significant changes in body fat between groups, maintaining a PI/r-based regimen was associated with a significant increase in VAT and TAT.